Dry Cupping Therapy and Muscle Energy Technique on Upper Crossed Syndrome
Effect of Combined Dry Cupping Therapy and Muscle Energy Technique on Upper Crossed Syndrome Patients. A Randomized Control Study
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
This study evaluated and compared the therapeutic efficacy of combining Dry Cupping therapy with the Muscle Energy Technique (MET) against each intervention applied independently, focusing on three core parameters: Neck Disability Index (NDI), Craniovertebral Angle (CVA), and Sagittal Shoulder-C7 Angle (SSA).
Methods: A pre-test post-test double-blinded randomized controlled trial design was employed. Seventy-six adults (aged 20-40 years) diagnosed with UCS were randomly allocated into four equal experimental groups (n = 19 per group): Group A received combined dry cupping and MET with conventional therapy; Group B received dry cupping with conventional therapy; Group C received MET with conventional therapy; and Group D received conventional therapy alone. Interventions were conducted over an 8-week period. Primary outcomes included functional impairment via the Arabic version of the NDI, and objective sagittal alignment parameters (CVA and SSA) measured using precision photometry via the Kinovea software application.
Tipo de estudio
Tipo de estudio
Inscripción (Actual)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Giza, Egipto
- Cairo University
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Participant inclusion was restricted to individuals between 20 and 40 years of age.
- The exact diagnostic criteria required a baseline craniovertebral angle (CVA) of less than 48 degrees.
- a sagittal shoulder-C7 angle (SSA) of less than 52 degrees.
Exclusion Criteria:
- acute post-surgical conditions
- structural spinal deformities (e.g., severe fixed structural scoliosis)
- cervical radiculopathy, or localized dermal infections contradicting cupping application.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: Group A (Combined group)
Group A (Combined group): This group of nineteen subjects received combined dry cupping therapy, Muscle energy techniques, and conventional physical therapy.
|
19 subjects received combined dry cupping therapy, Muscle energy technique, and conventional physical therapy for eight weeks.
|
|
Experimental: Group B (Cupping group)
Group B (Cupping group): This group of nineteen subjects received dry cupping therapy and conventional physical therapy.
|
19 subjects received combined dry cupping therapy and conventional physical therapy for eight weeks.
|
|
Experimental: Group C (MET group)
Group C (MET group): This group of nineteen subjects received Muscle energy techniques and conventional physical therapy.
|
19 subjects received combined Muscle energy technique, and conventional physical therapy for eight weeks.
|
|
Comparador activo: Group D (Control group)
Group D (Control group): This group of nineteen subjects received conventional physical therapy alone
|
19 subjects received only conventional physical therapy for eight weeks.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Neck Disability Index (NDI)
Periodo de tiempo: At baseline and re assessed following 8 weeks
|
Perceived functional limitations resulting from regional impairment were measured using the validated Arabic version of the NDI questionnaire.
This instrument evaluates 10 clinical sections (including activities of daily living, concentration, and pain profiles) scored from 0 to 5 per item, yielding a cumulative score out of 50.
Higher aggregate indices represent greater functional disability.
|
At baseline and re assessed following 8 weeks
|
|
craniovertebral angle (CVA)
Periodo de tiempo: At baseline and re assessed following 8 weeks
|
This biomechanical index reflects the architectural severity of forward head posture.
It is defined as the angle formed between a horizontal line drawn through the spinous process of C7 and an intersecting line extending from the tragus of the ear to the C7 landmark.
CVA was measured using precision digital photogrammetry via the Kinovea software application.
|
At baseline and re assessed following 8 weeks
|
|
Sagittal Shoulder-C7 Angle (SSA)
Periodo de tiempo: At baseline and re assessed following 8 weeks
|
This geometric marker quantifies shoulder roundedness and anterior protraction.
It is formed by the intersection of a horizontal reference line passing through the lateral aspect of the acromion with a line drawn from the C7 spinous process to the lateral acromion.
SSA was measured using precision digital photogrammetry via the Kinovea software application.
|
At baseline and re assessed following 8 weeks
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- 012/006489
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .